240 G.A. Thakur et al.
HanusL,BreuerA,TchilibonS,ShiloahS,GoldenbergD,HorowitzM,PertweeRG,Ross
RA, Mechoulam R, Fride E (1999) HU-308: a specific agonist for CB(2), a peripheral
cannabinoid receptor. Proc Natl Acad Sci USA 96:14228–14233
HanusL,Abu-LafiS,FrideE,BreuerA,VogelZ,ShalevDE,KustanovichI,Mechoulam
R (2001) 2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1
receptor. Proc Natl Acad Sci U S A 98:3662–3665
Harrington PE, Stergiades IA, Erickson J, Makriyannis A, Tius MA (2000) Synthesis of
functionalized cannabinoids. J Org Chem 65:6576–6582
Herkenham M (1991) Characterization and localization of cannabinoid receptors in brain:
an in vitro technique using slide-mounted tissue sections. NIDA Res Monogr 112:129–
145
Herkenham M, Lynn AB, Little MD, Johnson MR, Melvin LS, de Costa BR, Rice KC (1990)
Cannabinoid receptor localization in brain. Proc Natl Acad Sci USA 87:1932–1936
Hillard CJ, Edgemond WS, Jarrahian A, Campbell WB (1997) Accumulation of N-arachido-
noylethanolamine (anandamide) into cerebellar granule cells occurs via facilitated dif-
fusion. J Neurochem 69:631–638
Hollister LE, Gillespie HK, Mechoulam R, Srebnik M (1987) Human pharmacology of 1S and
1R enantiomers of∆-3-tetrahydrocannabinol. Psychopharmacology (Berl) 92:505–507
Hosohata K, Quock RM, Hosohata Y, Burkey TH, Makriyannis A, Consroe P, Roeske WR,
Yamamura HI (1997a) AM630 is a competitive cannabinoid receptor antagonist in the
guinea pig brain. Life Sci 61:PL115–PL118
Hosohata Y, Quock RM, Hosohata K, Makriyannis A, Consroe P, Roeske WR, Yamamura
HI (1997b) AM630 antagonism of cannabinoid-stimulated [35S]GTPgS binding in the
mouse brain. Eur J Pharmacol 321:R1–R3
Howlett AC, Wilken GH, Pigg JJ, Houston DB, Lan R, Liu Q, Makriyannis A (2000) Azido-
and isothiocyanato-substituted aryl pyrazoles bind covalently to the CB1 cannabinoid
receptor and impair signal transduction. J Neurochem 74:2174–2181
Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA, Felder CC, Herkenham
M, Mackie K, Martin BR, Mechoulam R, Pertwee RG (2002) International Union of
Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev 54:161–
202
Huffmann JW, Dai D, Martin BR, Compton DR (1994) Design, synthesis and pharmacology
of cannabimimetic indoles. Bioorg Med Chem Lett 4:563–566
HuffmanJW,YuS,ShowalterV,AboodME,WileyJL,ComptonDR,MartinBR,BramblettRD,
Reggio PH (1996) Synthesis and pharmacology of a very potent cannabinoid lacking
a phenolic hydroxyl with high affinity for the CB2 receptor. J Med Chem 39:3875–
3877
Huffman JW, Liddle J, Yu S, Aung MM, Abood ME, Wiley JL, Martin BR (1999) 3-(1′,1′-
Dimethylbutyl)-1-deoxy-∆8-THC and related compounds: synthesis of selective ligands
for the CB2 receptor. Bioorg Med Chem 7:2905–2914
Huffman JW, Bushell SM, Miller JRA, Wiley JL, Martin BR (2002) 1-Methoxy-, 1-deoxy-11-
hydroxy- and 11-hydroxy-1-methoxy-∆8-tetrahydrocannabinols: new selective ligands
for the CB2 receptor. Bioorg Med Chem 10:4119–4129
HuffmanJW,MabonR,WuM-J,LuJ,HartR,HurstDP,ReggioPH,WileyJL,MartinBR
(2003a) 3-Indolyl-1-naphthylmethanes: new cannabimimetic indoles provide evidence
foraromaticstackinginteractionswiththeCB1cannabinoidreceptor.BioorgMedChem
11:539–549
Huffman JW, Miller JRA, Liddle J, Yu S, Thomas BF, Wiley JL, Martin BR (2003b) Structure-
activity relationships for 1′,1′-dimethylalkyl-∆8-tetrahydrocannabinols. Bioorg Med
Chem 11:1397–1410
Hynes JJ, Leftheris K, Wu H, Pandit CR, Chen P, Norris DJ, Chen BC, Zhao R, Kiener PA,
Chen X, Turk LA, Patil-koota V, Gillooly KM, Shuster DJ, McIntyre KW (2002) C-3
Amido-indole cannabinoid receptor modulators. Bioorg Med Chem Lett 12:2399–2402
Ibrahim MM, Deng H, Zvonok A, Cockayne DA, Kwan J, Mata HP, Vanderah TW, Lai J,
Porreca F, Makriyannis A, Malan TPJ (2003) Activation of CB2 cannabinoid receptors